CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Theragen Etex Co Limited Company Snapshot
Theragen Etex Co Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Theragen Etex Co Limited with three other companies in this sector in KOREA (SOUTH) : Dae Han New Pharm Co., Ltd. (2019 sales of 134.10 billion Korean Won [US$114.79 million] of which 81% was Finished Goods), Reyon Pharmaceutical Co Ltd (131.56 billion Korean Won [US$112.61 million] of which 33% was other finished goods), and Hyundai Pharmaceutical Company Limited (134.92 billion Korean Won [US$115.49 million] of which 81% was Pharmaceutical).

Sales Analysis. During the year ended December of 2019, sales at Theragen Etex Co Limited were 138.08 billion Korean Won (US$118.20 million). This is an increase of 17.5% versus 2018, when the company's sales were 117.47 billion Korean Won . This was the fourth straight year of sales growth at Theragen Etex Co Limited. Sales of Pharmaceutical Business Segment saw an increase of 24.0% in 2019, from 95.95 billion Korean Won to 118.99 billion Korean Won . Not all segments of Theragen Etex Co Limited experienced an increase in sales in 2019: sales of Healthcare and Genome Analysis Business fell 11.3% to 19.09 billion Korean Won .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Theragen Etex Co Limited
  Stock Performance Chart for Theragen Etex Co Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (9/25/2020): 10,450
(Figures in Korean Won )
1 Week -24.5%   13 Weeks -6.7%  
4 Weeks -5.9%   52 Weeks 43.9%  
 
Theragen Etex Co Limited Key Data:
  Ticker: 066700 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 138,083,445,013
(Year Ending Jan 2020).
Employees: 252
  Currency: Korean Won Market Cap: 330,778,980,950
  Fiscal Yr Ends: December Shares Outstanding: 31,653,491
  Share Type: Common Closely Held Shares: 5,525,498
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.